mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PSMB3
Gene summary
Basic gene Info.Gene symbolPSMB3
Gene nameproteasome (prosome, macropain) subunit, beta type, 3
SynonymsHC10-II
CytomapUCSC genome browser: 17q12
Type of geneprotein-coding
RefGenesNM_002795.3,
NR_104194.1,NR_104195.1,
Descriptionproteasome chain 13proteasome component C10-IIproteasome subunit beta type-3proteasome theta chain
Modification date20141207
dbXrefs MIM : 602176
HGNC : HGNC
Ensembl : ENSG00000277791
HPRD : 03709
Vega : OTTHUMG00000188503
ProteinUniProt: P49720
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PSMB3
BioGPS: 5691
PathwayNCI Pathway Interaction Database: PSMB3
KEGG: PSMB3
REACTOME: PSMB3
Pathway Commons: PSMB3
ContextiHOP: PSMB3
ligand binding site mutation search in PubMed: PSMB3
UCL Cancer Institute: PSMB3
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for PSMB3

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C129,I127G128SSTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PSMB3
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
I127G128S-0.9073104
C129G128S-0.9073104
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PSMB3 from PDB

Top
Differential gene expression and gene-gene network for PSMB3
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PSMB3 and the right PPI network was created from samples without mutations in the LBS of PSMB3. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PSMB3
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PSMB3
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|investigationalDB00188BortezomibSmall molecule
ExperimentalDB08515(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDESmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PSMB3 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
3BVCARFILZOMIB, BOUND FORMN-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4- PHENYLBUTANOYL}-L-LEUCYL-N-[(2R,3S,4S)-1,3-DIHYDROXY- 2,6-DIMETHYLHEPTAN-4-YL]-L-PHENYLALANINAMIDE4r67lI127
3BVCARFILZOMIB, BOUND FORMN-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4- PHENYLBUTANOYL}-L-LEUCYL-N-[(2R,3S,4S)-1,3-DIHYDROXY- 2,6-DIMETHYLHEPTAN-4-YL]-L-PHENYLALANINAMIDE4r67zI127
3BVCARFILZOMIB, BOUND FORMN-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4- PHENYLBUTANOYL}-L-LEUCYL-N-[(2R,3S,4S)-1,3-DIHYDROXY- 2,6-DIMETHYLHEPTAN-4-YL]-L-PHENYLALANINAMIDE4r67JI127 C129


Top
Conservation information for LBS of PSMB3
Multiple alignments for P49720 in multiple species
LBSAA sequence# speciesSpecies
C129LDLIGCPMVTD4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
C129MDSIGAKELAK2Arabidopsis thaliana, Arabidopsis thaliana
C129MDTIGCVSAPR1Caenorhabditis elegans
C129MDLIGCPNAPD1Drosophila melanogaster
C129MDCIGAKELAK1Oryza sativa subsp. japonica
C129FDLIGCIDEAK1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C129FDSIGCIDFAE1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
D125FICSLDLIGCP4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
D125FICTMDSIGAK2Arabidopsis thaliana, Arabidopsis thaliana
D125YICCMDTIGCV1Caenorhabditis elegans
D125FICNMDLIGCP1Drosophila melanogaster
D125FICTMDCIGAK1Oryza sativa subsp. japonica
D125FIAGFDLIGCI1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
D125FICGFDSIGCI1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
E106GPYYTEPVIAG4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
E106GSYFTEPLVAG1Caenorhabditis elegans
E106GPYFIEPVVAG1Drosophila melanogaster
E106GPYFCQPVIAG1Oryza sativa subsp. japonica
E106GPFLCQPVIAG1Arabidopsis thaliana
E106GPYLCQPVIAG1Arabidopsis thaliana
E106GPYFVGPVVAG1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
E106GPYFSFPVVAG1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
I127CSLDLIGCPMV4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
I127CTMDSIGAKEL2Arabidopsis thaliana, Arabidopsis thaliana
I127CCMDTIGCVSA1Caenorhabditis elegans
I127CNMDLIGCPNA1Drosophila melanogaster
I127CTMDCIGAKEL1Oryza sativa subsp. japonica
I127AGFDLIGCIDE1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
I127CGFDSIGCIDF1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
L126ICSLDLIGCPM4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
L126ICTMDSIGAKE2Arabidopsis thaliana, Arabidopsis thaliana
L126ICCMDTIGCVS1Caenorhabditis elegans
L126ICNMDLIGCPN1Drosophila melanogaster
L126ICTMDCIGAKE1Oryza sativa subsp. japonica
L126IAGFDLIGCID1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
L126ICGFDSIGCID1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
M411Homo sapiens, Caenorhabditis elegans, Drosophila melanogaster, Rattus norvegicus, Mus musculus, Bos taurus, Oryza sativa subsp. japonica, Arabidopsis thaliana, Arabidopsis thaliana, Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Schizosaccharomyce
R99LLYEKRFGPYY4Homo sapiens, Rattus norvegicus, Mus musculus, Bos taurus
R99LAYQHRFGSYF1Caenorhabditis elegans
R99FLYEHRFGPYF1Drosophila melanogaster
R99LLYEKRFGPYF1Oryza sativa subsp. japonica
R99ILYEKRFGPFL1Arabidopsis thaliana
R99ILYEKRFGPYL1Arabidopsis thaliana
R99SLYERRFGPYF1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
R99TLYEKRFGPYF1Schizosaccharomyces pombe (strain 972 / ATCC 24843)


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas